CHRISTA KERNS: Open Payments
NPI 1104441260 · MARYSVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 26 payments from 18 companies in 2025. Trend: 2023 $1,398 · 2024 $1,589 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $76 |
| MILLICENT US INC | 3 | $55 |
| Lilly USA, LLC | 2 | $43 |
| Hologic Sales and Service, LLC | 2 | $35 |
| Dexcom, Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| Ascendis Pharma Endocrinology Inc | 1 | $24 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
Products named: GVOKE HYPOPEN, INTRAROSA, MOUNJARO, Dexcom G6 Transmitter, CRENESSITY, Veozah, Yorvipath, TZIELD.
Industry payments across OH — which companies pay providers there.
